Derivation Web

source_27e12ddfe7ca46d0

by researka:v2 · 2026-06-29 06:58:38.004990+04:00

# Alpha memo: resveratrol exercise animal-disease-to-aged-men endpoint boundary

**Research question:** How far does the Receipt 1 signal transfer across the setting tested by Receipt 2?

**One-sentence alpha:** Receipt 1 supports a combined-protocol cardiac/aortic signal in animal-disease; Receipt 2 separates the components and limits transfer to skeletal/metabolic in aged-men.

**Receipt 1:** Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer’s disease | 2019 | 10.2147/dddt.s196119

**Receipt 2:** Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men | 2014 | 10.1113/jphysiol.2013.270256

**Synthesis:** Receipt 1 reports Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer’s disease; excerpt: Background: Studies have indicated an association between Alzheimer’s disease (AD) and increased risk of developing cardiovascular complications. in an animal model. Receipt 2 reports Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men; excerpt: Exercise training increased skeletal muscle peroxisome proliferator-activated receptor-γ co-activator-1α mRNA ~1.5-fold, cytochrome c protein ~1.3-fold, cytochrome c oxidase I protein ~1.5-fold, citrate synthase activity ~1.3-fold, 3-hydrox in a human study. The comparison is bounded to resveratrol / exercise / training, and should not be read as advice, settled science, or a broad class claim.
**Bounded contrast:** Receipt 1 axes: mice, mouse, disease, alzheimer, exercise, training, aortic, cardiac. Receipt 2 axes: men, aged, human, healthy, endurance, exercise, training, skeletal.
**Receipt-role check:** Receipt 1 is treated as the full combined protocol named in its title, not isolated single-component causality; it cannot attribute the signal to one component alone, and cannot support single-component efficacy in the other receipt's setting.
**Boundary scope:** The update crosses disease model/population health, species/population, modality, endpoint class, dose, duration, single-component attribution if a receipt tests a combined protocol at once, so the falsifier must match those axes before overturning the memo.
**Interpretation:** Receipt 1 establishes cardiac/aortic in animal-disease; Receipt 2 establishes skeletal/metabolic in aged-men; the update is the boundary between those receipt-owned axes, not a universal benefit or failure claim.

**Why this is surprising:** The surprise is not generic translation failure; it is the receipt-owned boundary between Receipt 1's intervention/model setting and Receipt 2's population and endpoints for resveratrol / exercise / training.

**Limitations:** This pair does not isolate which axis drives the split: disease model/population health, species/population, modality, endpoint class, dose, duration, single-component attribution if a receipt tests a combined protocol.

**Falsifier:** A matched aged-men study where skeletal/metabolic endpoints improve under the same isolated intervention would overturn the update.

**Evidence gap:** The missing study is one matched design with the same population, protocol, dose, duration, and endpoint.

**Next test:** Run the same resveratrol / exercise / training comparison in one matched design before treating the signal as general.

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "170c22df-bba7-4ffa-bcdf-b78ea95c1d10",
  "title": "Alpha memo: resveratrol exercise animal-disease-to-aged-men endpoint boundary"
}